» Articles » PMID: 10220744

A Transient Increase in C-myc Precedes the Transdifferentiation of Hepatic Stellate Cells to Myofibroblast-like Cells

Overview
Journal Liver
Specialty Gastroenterology
Date 1999 Apr 30
PMID 10220744
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Aims/background: Liver stellate cells are transdifferentiated to collagen-producing myofibroblast-like cells in vivo during liver injury or when placed in culture. The purpose of this study was to determine the presence of retinoids and the expression of the immediate early genes as they relate to the transdifferentiation of liver stellate cells in culture.

Methods: Rat liver stellate cells were studied immediately after isolation or sequentially after culture for varying periods of time. RNA was isolated and specific messages were determined by RT-PCR. Cells were also isolated for determination of retinoid autofluorescence and immunofluorescent staining with specific antibodies by laser confocal microscopy.

Results: c-fos message and immunoprotein were high in the freshly isolated cells prior to culture, while c-myc expression increased markedly after one day of culture. Both c-fos and c-myc gene expression decreased prior to the transdifferentiation of the cells to myofibroblast-like cells and to the increase in alpha 1(I) and alpha 2(I) collagen messages and collagen production. The presence of retinoid autofluorescence and retinoic acid receptor (RAR-alpha and RAR-beta) messages and RAR-beta immunoprotein persisted during initial transdifferentiation of the stellate cells.

Conclusions: This study shows a high initial level of c-fos expression and a transient increase in c-myc expression followed by a decrease to lower levels prior to transdifferentiation and collagen production by stellate cells. A total loss of retinoid autofluorescence or a decrease in RAR-alpha or RAR-beta are not required for initial transdifferentiation of stellate cells or collagen production.

Citing Articles

Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis.

Bhattacharya D, Becker C, Readhead B, Goossens N, Novik J, Fiel M Sci Rep. 2021; 11(1):20827.

PMID: 34675338 PMC: 8531016. DOI: 10.1038/s41598-021-99008-2.


Pyruvate kinase M2 regulates fibrosis development and progression by controlling glycine auxotrophy in myofibroblasts.

Satyanarayana G, Turaga R, Sharma M, Wang S, Mishra F, Peng G Theranostics. 2021; 11(19):9331-9341.

PMID: 34646373 PMC: 8490528. DOI: 10.7150/thno.60385.


Down-Regulation of CXXC5 De-Represses MYCL1 to Promote Hepatic Stellate Cell Activation.

Wu X, Dong W, Kong M, Ren H, Wang J, Shang L Front Cell Dev Biol. 2021; 9:680344.

PMID: 34621736 PMC: 8490686. DOI: 10.3389/fcell.2021.680344.


Indian Hedgehog links obesity to development of hepatocellular carcinoma.

Chong Y, Lim T, Fu Y, Shin E, Tergaonkar V, Han W Oncogene. 2018; 38(12):2206-2222.

PMID: 30470823 DOI: 10.1038/s41388-018-0585-5.


Regulation of hepatic stellate cell proliferation and activation by glutamine metabolism.

Li J, Ghazwani M, Liu K, Huang Y, Chang N, Fan J PLoS One. 2017; 12(8):e0182679.

PMID: 28797105 PMC: 5552314. DOI: 10.1371/journal.pone.0182679.